TY - JOUR
T1 - Low-dose bromocriptine therapy in Parkinson's disease
T2 - Double-blind, placebo-controlled study
AU - Staal-Schreinemachers, AL
AU - Wesseling, H
AU - Kamphuis, DJ
AU - van der Burg, W
AU - Lakke, JPWF
PY - 1986/2
Y1 - 1986/2
N2 - Twenty-one de novo parkinsonian patients in stage I to III of the Hoehn and Yahr scale completed a 6-month, double-blind, placebo-controlled study. Low-dose bromocriptine (15 mg daily) was effective. Rigidity improved more than tremor or bradykinesia. Sustained satisfactory benefit was seen only in patients with mild Parkinson's disease.
AB - Twenty-one de novo parkinsonian patients in stage I to III of the Hoehn and Yahr scale completed a 6-month, double-blind, placebo-controlled study. Low-dose bromocriptine (15 mg daily) was effective. Rigidity improved more than tremor or bradykinesia. Sustained satisfactory benefit was seen only in patients with mild Parkinson's disease.
U2 - 10.1212/wnl.36.2.291
DO - 10.1212/wnl.36.2.291
M3 - Comment/Letter to the editor
SN - 0028-3878
VL - 36
SP - 291
EP - 293
JO - Neurology
JF - Neurology
IS - 2
ER -